SUD & Emergency Preparedness | ACMT Total Tox Course
-
Register
- Non-member - Tier I - $225
- Non-member - Tier II - $225
- Non-member - Tier III - $150
- Non-member - Tier IV - $100
- Member - Tier I - $200
- Member - Tier II - $200
- Member - Tier III - $125
- Member - Tier IV - $75
From American College of Medical Toxicology (ACMT), dive into Substance Use Disorder & Emergency Preparedness! In the first half of this activity, you’ll explore topics related to substance use, including opioid addiction, cannabis toxicity, emerging substances, drug screening challenges, pulmonary irritants, and the impact of mitochondrial asphyxiants on first responders in chemical suicide cases. The activity then transitions to disaster preparedness, covering radiation types and symptom management, nerve agents, and a brief history of bioterrorism and identification of key agents. Interactive case panels with expert insights will further deepen your understanding of substance use disorder and disaster preparedness.
The content of this course consists of recordings from the live, virtual SUD & Emergency Preparedness activity of the 2024 ACMT Total Tox Course on November 8, 2024. The content has been edited and packaged into this on-demand version featuring 13 asynchronous lectures from experts in the field of medical toxicology.
Registration for this course includes 90 day access to the on-demand material and up to 8.00 Continuing Education credits.
Target Audience
This activity is designed for a diverse audience including physicians, pharmacists, advanced practice nurses, nurses, physician assistants, medics, EMTs, SPIs, laboratorians, poison center educators, first responders, and residents and students eager to expand their expertise.
Continuing Education
Enduring continuing education credits for Pharmacists, Physicians, Physician Associates, Nurses, and Nurse Practitioners is provided by AKH Inc., Advancing Knowledge in Healthcare. It is expected that learners will receive up to 8.0 credits for learning and change.
For more information, click here.
Learning Objectives
After Completing This Program You Should Be Able To:
- Discuss psychoactive substances as well as the diagnosis and treatment approaches for substance use disorders.
- Describe medication-assisted treatments for opioid use disorder, focusing on buprenorphine, methadone, and naltrexone.
- Explain medical management principles for CBRNE and other hazmat situations
Questions?
Please write to ACMT at events@acmt.net
If you are interested in the other sections of this course, check out the links below!
Syllabus
Total Activity Length: approximately 8 hours (472 minutes)
PRE-TEST | 15 min
12 multiple-choice questions to ascertain your baseline knowledge on the topic.
The New Dangers of Opioid Addiction | 42 min
Lewis Nelson, MD, FACEP Chair of Emergency Medicine, Rutgers New Jersey Medical School, Newark, NJ
Dr. Nelson will describe opioid use disorder and explain how to initiate treatment for opioid use disorders. He will also highlight harm reduction efforts that can reduce the adverse consequences of opioid use.
Management Options for Opioid Use Disorder | 30 min
Rachel Wightman, MD, FACMT Assistant Professor of Emergency Medicine, The Warren Alpert Medical School of Brown University, Providence, RI
Dr. Wightman will review the misuse, abuse, & criteria for diagnosing opioid use disorder. She will identify psychosocial treatments for opioid use disorder and describe the medication-assisted treatments for Buprenorphine, Methadone, and Naltrexone.
Cannabis & Cannabis Toxicity | 28 min
Mark Neavyn, MD, FACMT Medical Director & Emergency Medicine Physician, Northern New England Poison Center & Maine Medical Center, Portland, ME
Dr. Neavyn will examine the symptoms of cannabis toxicity and describe the treatment approach to cannabis toxicity.
What's New in Your Neighborhood? | 19 min
Stephanie Weiss, MD, PhD Staff Clinician, Translational Addiction Medicine Branch, National Institute on Drug Abuse, Baltimore, MD
Dr. Weiss will discuss the epidemiology of new fentalogues and explain how to initiate treatment for fentanyl-related overdose.
Drug Screen Pitfalls | 29 min
Paul M. Wax, MD, FACMT Executive Director, American College of Medical Toxicology (ACMT), Phoenix, AZ
Dr. Wax will Identify toxicology tests available in the ED. He will discuss which tests should be requested in specific situations and describe how test ordering changes treatment outcomes.
Inhaled Toxicants: Simple Asphyxiants & Respiratory Irritants | 43 min
Charles McKay, MD, FACMT Associate Medical Director, CT Poison Control Center, University of Connecticut School of Medicine, Farmington, CT
Dr. McKay will discuss the role of water solubility in the clinical presentation of pulmonary irritants and describe the clinical presentation of pulmonary irritants.
Chemical Suicide & Mitochondrial Asphyxiants | 29 min
Paul M. Wax, MD, FACMT Executive Director, American College of Medical Toxicology (ACMT), Phoenix, AZ
Dr. Wax will return to examine the sources and uses of chemical asphyxiants, their basic mechanisms of toxicity, and their clinical presentations. He will identify the differences between simple asphyxiants and chemical asphyxiants and compare therapies used to treat asphyxiant poisoning.
Carbon Monoxide Poisoning: High Flow Oxygen or the Hyperbaric Chamber | 27 min
Kelly Johnson-Arbor, MD, FACEP, FUHM, FACMT Medical Director, National Capital Poison Center & MedStar Georgetown University Hospital, Washington, DC
Dr. Johnson-Arbor will identify different types of radiation, describe the consequences of exposure to radiation, and discuss the diagnosis and management of radiation casualties and radiation mass casualty events.
Disaster Preparedness #1: Radiation Events | 32 min
Joseph K. Maddry, Lt Col, USAF, MC, FS, MD, FACMT Deputy Commander, Department of Emergency Medicine, US Army Institute of Surgical Research, Houston, TX
Dr. Maddry will discuss the diagnosis and management of radiation casualties and radiation mass casualty events. He will also identify different types of radiation and describe the consequences of exposure to radiation.
Disaster Preparedness #2: Organophosphates & New Agents | 34 min
Christina Hantsch, MD, FACEP, FACMT, FAACT Emergency Physician and Medical Toxicologist, Loyola University Chicago Stritch School of Medicine Maywood, IL
Dr. Hantsch will discuss management options for patients with organophosphate insecticide or nerve agent toxicity and explain cholinergic toxidrome. She will list specific organophosphate insecticides and chemical weapon nerve agents.
Disaster Preparedness #3: Other Chemical & Biological Terrorism | 44 min
Aaron Frey, DO Emergency Medicine Attending Physician and Medical Toxicology Fellow, Richmond Emergency Physicians, Inc. & University of Virginia, Richmond, VA
Dr. Frey will examine the diagnosis and management of casualties resulting from terrorism and mass casualty events and discuss the history of bioterrorism as a tool for warfare. He will explain and evaluate the agents used in bioterrorist events.
Case Panel - Addiction | 41 min
Several speakers from previous lectures return to review clinical cases on addiction.
Case Panel - Emergency Preparedness | 44 min
Several speakers from previous lectures return to review educational cases on emergency preparedness.
POST-TEST | 15 min
Retake the same 12 multiple-choice questions asked during the pre-test and compare your scores to assess your learning.
Aaron Frey, DO
Core Faculty & Medical Toxicologist
WellSpan Health at York Hospital
Dr Aaron Frey is an emergency medicine physician and medical toxicologist. He studied government and international studies at Campbell University in North Carolina and Spanish at Middlebury College in Vermont. He worked as a firefighter, emergency medical technician, and search and rescue diver during his undergraduate career. The experiences he had in those roles are what influenced him to become a physician. His particular interests include hazardous materials and chemical, biological, radiological, and nuclear (CBRN) weapons, remote, austere, and wilderness medicine, and damage control resuscitation. He currently practices emergency medicine and toxicology at the Wellspan York Hospital in York, PA and holds an academic appointment of assistant professor of emergency medicine and medical toxicology at Drexel University College of Medicine.
Ashley Haynes, MD, FACEP
Medical Toxicologist, Addiction Medicine Specialist
Veterans Health Administration
Dr. Haynes completed training in a combined emergency medicine-internal medicine program in 2014, and a toxicology fellowship at UTSW in 2016. She has been treating substance use disorders as part of her practice since that time and is board certified in addition medicine. She currently works for the VA at the Robert J Dole Veterans Medical Center in Wichita, KS, treating patients in a residential treatment center, as well as clinic, and performing bedside consults.
Christina Hantsch, MD, FACEP, FAACT, FACMT
Emergency Physician and Medical Toxicologist
Dr. Hantsch is a graduate of the Honors Program in Medical Education at Northwestern University. She completed an emergency medicine residency, including a year as chief resident, at the Medical College of Wisconsin and then continued her training in a medical toxicology fellowship at Vanderbilt University. After her fellowship, she spent nearly 22 years at Loyola University Chicago Stritch School of Medicine and Loyola University Medical Center. There, she established an inpatient toxicology clinical service and clinical rotations for graduate medical trainees and students in multiple fields. With an interest in medication management and safety, she joined the hospital Pharmacy and Therapeutics Committee, serving as member for 6 years before being appointed chair and leading the committee for another 6 years. Dr. Hantsch earned the academic rank of Professor of Emergency Medicine, was Director of the Division of Toxicology, and Director of Academic Affairs in the Department of Emergency Medicine. As a clinical faculty member, she was appointed to the Stritch Committee on Academic Rank and Tenure, serving for 7 years including 2 as a subcommittee chair leading revision of the clinician educator track guidelines. In 2018, she was the founding Program Director of the Loyola emergency medicine residency. Dr. Hantsch served for more than 8 years as Medical Director of the Illinois Poison Center. In addition, she is a regular organizer and contributor to many local, regional, and national/international continuing education programs. After leaving academics, she worked for the U.S. FDA in pharmacovigilance for a year. As of 2022, she is board certified in addiction medicine in addition to emergency medicine and medical toxicology. Dr. Hantsch was elected to the ACMT Board of Directors in 2021, is a member of the Education Committee, and chair of the Practice Committee.
Robert Hendrickson, MD
Professor of Emergency Medicine, Medical Director, Program Director
Oregon Health and Science University, Oregon Poison Center, OHSU Fellowship in Medical Toxicology
Dr. Hendrickson graduated from the State University of New York, Downstate College of Medicine, and completed training in Emergency Medicine and Medical Toxicology at the Medical College of Pennsylvania. He is a Professor of Emergency Medicine at Oregon Health and Sciences University where he is Chief of the Section of Medical Toxicology, Program Director for the fellowship in medical toxicology, and the Medical Director of the Oregon Poison Center.
Kelly Johnson-Arbor, MD, FACEP, FUHM, FACMT
Medical Toxicology Physician and Medical Director of Hyperbaric Medicine
MedStar Georgetown University Hospital
Dr. Kelly Johnson-Arbor is a medical toxicology and hyperbaric medicine physician at MedStar Georgetown University Hospital. She is triple board-certified in Emergency Medicine, Medical Toxicology, and Undersea and Hyperbaric Medicine. She completed her undergraduate education at Harvard College and earned her medical degree from Loyola University Stritch School of Medicine. She completed a residency in Emergency Medicine at the University of Rochester, followed by a fellowship in Medical Toxicology at the University of Connecticut. From 2018 through 2023, she served as the co-medical director of National Capital Poison Center, and she has provided medical toxicology consultation services to the Connecticut Poison Control Center since 2006. Since 2015, she has served as medical director of hyperbaric medicine at MedStar Georgetown University Hospital, and she also maintains an outpatient medical toxicology clinic at this facility. She is an Assistant Professor of Plastic Surgery and Emergency Medicine at the Georgetown University School of Medicine and serves as an associate faculty member of the MedStar Institute for Quality and Safety.
An avid researcher and writer, Dr. Johnson-Arbor has published numerous articles in peer-reviewed medical journals including New England Journal of Medicine, JAMA Internal Medicine, and Annals of Emergency Medicine. She enjoys teaching toxicology principles and hyperbaric medicine to the public as well as medical professionals. Her work as both a hyperbaric medicine and medical toxicology physician has allowed her to gain unique perspectives on the diagnosis and treatment of acute and chronic carbon monoxide poisoning as well as their long-term complications.
Joseph K. Maddry, Lt Col, USAF, MC, FS, MD, FACMT
Deputy Commander
Department of Emergency Medicine, US Army Institute of Surgical Research
Lt Col Maddry earned his Bachelor’s Degree from the US Air Force Academy in 2001 as a Distinguished Graduate. His first assignment was as Officer in Charge of Bioenvironmental Engineering at Minot Air Force Base, North Dakota. During his tenure, he led his unit’s response to the largest anhydrous ammonia spill in U.S. history. He then attended medical school at the Uniformed Services University, earning Alpha Omega Alpha membership honors. He completed his emergency medicine residency at SAUSHEC and his medical toxicology fellowship at the Rocky Mountain Poison and Drug Center in Denver, Colorado.
Following fellowship, Lt Col Maddry returned to Brooke Army Medical Center as an emergency physician and medical toxicologist. He served as Chief of the BAMC Simulation Center from 2014 to 2015. Subsequently, he served as Director of the US Air Force En route Care Research Center (ECRC) from 2015 to 2020. In this position, he oversaw 20 personnel and a $14.8 million research portfolio. He is an author of over 100 peer reviewed publications and 150 research presentations and has been awarded over $28 million in research grants. The Society of Academic Emergency Medicine recognized Dr. Maddry’s research as one of the best publications of 2014. Lt Col Maddry was awarded the Defense Health Board Early Career Investigator Award, the 2017 USAF Outstanding Achievement in Clinical Research award and the 2018 Military Health System Research Symposium Small Team Research Accomplishment Award for Excellence.
Lt Col Joseph Maddry is currently the Deputy Commander of the US Army Institute of Surgical Research, overseeing over 700 personnel focused on optimizing combat casualty care. Dr. Maddry also serves as Director of Medical Toxicology at Brooke Army Medical Center and as the Director of the Clinical Resuscitation, Emergency Sciences, Toxicology, and Triage (CREST2) Research Program. He leads the development of the next generation of military researchers by serving as the Director of the SAUSHEC Military Emergency Medicine Research Fellowship and as Director of the Clinician Scientist Investigator Opportunity Network (CSION).
He is an Associate Professor of Emergency Medicine with the Uniformed Services University and has academic appointments at the University of Texas Health, Texas A&M, and the University of Colorado Denver. Lt Col Maddry has served in Afghanistan, Iraq, Haiti, Japan and Burkina Faso.
Charles McKay, MD, FACMT
Associate Medical Director
CT Poison Control Center, University of Connecticut School of Medicine
Dr. McKay was trained in Anatomic and Surgical Pathology, Internal Medicine, Emergency Medicine, Medical Toxicology and was a Medical Director of Occupational Health and Medical Review Officer for a hospital system during more than 30 years of clinical practice, during which he provided toxicology consultation at 3 hospitals, directed a medical toxicology fellowship training program, and provided medical oversight of a regional poison control center. He provides medical legal consultation across the country on toxicology-related issues, and has testified in nearly 100 cases, many related to questions of alcohol- and -drug-induced impairment.
Howard McKinney, PharmD, DABAT, FAACT
Secretary-Treasurer
American Board of Applied Toxicology & North American Society of Toxinology
Dr McKinney graduated in 1971 from the University of California San Diego, Revelle College with a Bachelor of Arts degree (BA), Biology major, Spanish Literature minor.
In 1978 he graduated from UCSF School of Pharmacy with a Doctor of Pharmacy degree (PharmD), and was recruited to be a founding staff member of the San Francisco Poison Center, where he worked until 1992.
In 1992 he passed the Boards to become a Diplomate of the American Board of Applied Toxicology DABAT), and was hired as a Clinical Pharmacist in Critical Care at Univ Calif Davis Medical Center in Sacramento California (UCDMC).
In 2018 he was approved as a Fellow of the American Academy of Clinical Toxicology (FAACT), and retired from UCDMC. He continues his work as Secretary-Treasurer of ABAT and NAST (North American Society of Toxincology), as well as his love of herpetology, hiking, photography, videography and music.
Mark Neavyn, MD, FACMT
Medical Director & Emergency Medicine Physician
Northern New England Poison Center & Maine Medical Center
Mark Neavyn, M.D. joined Maine Medical Center as the Medical Director for the Northern New England Poison Center in 2020. After earning his Bachelor of Arts degree in biology from Augustana College, he went on to earn his medical degree at Jefferson Medical College. He then completed his residency in emergency medicine at Drexel University, followed by a fellowship in Medical Toxicology at the University of Massachusetts.
His clinical interests include treatment and stabilization of patients after poisoning, drug overdose, and environmental exposures. He is particularly interested in the public health implications of cannabis use and emerging trends in novel psychoactive substances.
In his spare time Dr. Neavyn enjoys running on the beautiful trails in and around Portland, Maine.
Lewis Nelson, MD, MBA, FACMT, FASAM
Chair of Emergency Medicine
Rutgers New Jersey Medical School
Lewis S. Nelson, MD is Professor and Chair of the Department of Emergency Medicine at Rutgers New Jersey Medical School, Chief of Service for the Emergency Department at University Hospital of Newark, and Senior Consultant to the New Jersey Poison Information & Education System. Dr. Nelson is board certified in emergency medicine, medical toxicology, and addiction medicine. His areas of specific interest include preventing and managing the consequences of opioid and other substance use, multimodal pain management strategies, health policy, and medication safety.
Dr. Nelson has served as President of American College of Medical Toxicology and on the Board of Directors of both the American Board of Emergency Medicine and the Accreditation Council for Continuing Medical Education. He is currently the president of Association of Academic Chairs in Emergency Medicine. He is a long time consultant for several governmental agencies including the Centers for Disease Control and Prevention, the Department of Homeland Security, and the Food and Drug Administration. He is an editor of the textbook “Goldfrank’s Toxicologic Emergencies.
Paul M. Wax, MD, FACMT
Executive Director
American College of Medical Toxicology (ACMT)
Dr. Wax is the Executive Director of the American College of Medical Toxicology. He received his B.A from Dartmouth College, his M.D. from the Mount Sinai School of Medicine, his Emergency Medicine training at the UCLA Hospitals, and his Medical Toxicology training at Bellevue Medicine Center / New York University. He is Board-certified in both Medical Toxicology and Emergency Medicine, and is a Fellow of the American College of Medical Toxicology.
Stephanie Weiss, MD, PhD
Staff Clinician, Translational Addiction Medicine Branch
National Institute on Drug Abuse
Dr. Stephanie Weiss is the Staff Research Physician serving the Translational Addiction Medicine Branch of the National Institute on Drug Abuse’s Intramural Research Program. After earning a Ph.D. in pharmaceutical chemistry, Dr. Weiss received her medical degree in 2011. She is board certified in emergency medicine, addiction medicine, and medical toxicology and was selected to participate in the Boston University Research in Addiction Medicine Scholars Program prior to joining NIDA. Dr. Weiss is responsible for providing optimal, safe, and ethical care to study participants and clinical support toward the TAMB mission conducting inpatient and outpatient proof-of-concept human laboratory studies. Her research interests include novel psychoactive substances, medication misuse, and improving interpretation of urine drug testing.
Rachel Wightman, MD, FACMT
Assistant Professor of Emergency Medicine
The Warren Alpert Medical School of Brown University
Dr. Wightman is an Assistant Professor of Emergency Medicine at Alpert Medical School of Brown University. She is a triple board-certified practicing physician in medical toxicology, addiction medicine, and emergency medicine. She serves as Director of Toxicology Education for Brown Emergency Medicine and as faculty in the Addiction Medicine Fellowship at Rhode Island Hospital. She completed medical toxicology fellowship and emergency medicine residency at New York University School of Medicine/ Bellevue Hospital Center.
Dr. Wightman’s primary clinical expertise is in the evaluation and management of drug toxicity syndromes in complex medical patients and enhancing medication safety for high-risk drugs. Her research is focused on evaluation and tracking of emerging drug trends, cannabis hyperemesis syndrome, and medications for treatment of opioid use disorder.
Registration Rates
Registration includes:
- 90-day access to all course content
- Access to the Speaker slides
- 8.0 Continuing Education Certificate. Available credits: Continuing Medical Education (CME), Continuing Nursing Education (CNE), Continuing Pharmacy Education (CPE), Continuing Medical Education for Physician Associates (AAPA CME), and Continuing Education for Nurse Practitioners (AANP CE).
Member Rates
Member Tier I: Full, Affiliate, International, Emeritus |
$200 |
Member Tier II: Fellows |
$200 |
Member Tier III: Residents, International - Developing Country |
$125 |
Member IV: Medical Students |
$75 |
Non-Member Rates
Non-member Tier I: Physicians, Pharmacists, Lawyers, "Other" |
$225 |
Non-member Tier II: Fellows, SPIs, Nurses, etc. |
$225 |
Non-member Tier III: Educators & Emergency Responders |
$150 |
Non-member IV: Residents & Students |
$100 |
ACMT Membership
ACMT Members receive a discounted rate. Interested in becoming an ACMT Member? Contact our Membership Team at membership@acmt.net. Learn more at: www.acmt.net/membership
Package Rates
Sign up for the full ACMT Total Tox Course and save $100!
Refunds and Cancellations
For information on ACMT's Cancellation and refund policy, click here.
Questions?
For any questions, please email us at events@acmt.net.
Instructions
Once you have completed your registration:
- Click on the Contents tab. This is where you will be able to see all lectures and required content for this course.
- Complete the Pre-Test. You are not required to pass the Pre-Test, this is to test your skills before you begin the on-demand course.
- Watch all lectures and case panels. Learners will be required to watch at least 3/4 of the video before it will be marked as complete.
- Complete the Post-Test. These questions are based on content from the lectures to gauge your comprehension of the lectures. It requires a 80% to pass.
- Complete the Course and CE Survey. These questions are required to claim your CE certificate.
- Claim your CE certificate. Once you have claimed your CE credit, you will not be able to change your CE certificate.
Full credit can only be claimed after completion of all required components.
Hardware/Software Requirements
Computer or Other Internet-Enabled Device; Internet Connection; Browser.
Materials
None.
Prerequisites
None.
Format
This is a self-guided course with CME, CNE, CPE, AAPA CME, and AANP CE.
Need Assistance or Have Questions?
For assistance logging in, accessing content, purchasing or completing Continuing Education credits, or for other questions, please contact us at events@acmt.net or visit our FAQ page.
If you are in need of accessible learning accommodations, please contact events@acmt.net for additional assistance.
Continuing Education
ACMT Total Tox Course - SUD & Emergency Preparedness
On-demand Course
Release Date: December 6, 2024
Expiration Date: December 6, 2025
CE credit provided by AKH Inc., Advancing Knowledge in Healthcare.
Criteria for Success
To obtain a certificate of completion, a score of 70% or better on the post-test is required. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your certificate. You must participate in the entire activity to receive credit. There is no fee to participate in this activity. If you have questions about this activity, please contact AKH Inc. at events@acmt.net.
Please claim your credit by December 6, 2025
If you have questions about this CE activity, please contact AKH Inc at bethany@akhcme.com
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and American College of Medical Toxicology (ACMT). AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive 8.0 Interprofessional Continuing Education (IPCE) credit for learning and change.
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and American College of Medical Toxicology (ACMT). AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive 8.0 Interprofessional Continuing Education (IPCE) credit for learning and change.
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 8.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
Credit being awarded: 8.0 ANCC contact hours.
Nurse Practitioners
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and American College of Medical Toxicology (ACMT). AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 8.0 contact hour(s) (which includes 8.0 hour(s) of pharmacology).
Physician Associate
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 8.0 AAPA Category 1 CME credits. Approval is valid until 12/6/2025.
PAs should only claim credit commensurate with the extent of their participation.
Pharmacists
AKH Inc., Advancing Knowledge in Healthcare designates this continuing education activity for 8.0 contact hour
Commercial Support
This activity is supported from an independent medical education grant from BTG international lnc.,
Disclosures
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to optout@akhcme.com with your information with "Opt Out" in the subject line.